US11109661B2 - System, device and method of facial remodeling - Google Patents
System, device and method of facial remodeling Download PDFInfo
- Publication number
- US11109661B2 US11109661B2 US15/863,174 US201815863174A US11109661B2 US 11109661 B2 US11109661 B2 US 11109661B2 US 201815863174 A US201815863174 A US 201815863174A US 11109661 B2 US11109661 B2 US 11109661B2
- Authority
- US
- United States
- Prior art keywords
- facial mask
- lifting strap
- grounding
- facial
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000001815 facial effect Effects 0.000 title claims abstract description 129
- 238000007634 remodeling Methods 0.000 title claims abstract description 19
- 238000000034 method Methods 0.000 title abstract description 27
- 239000000203 mixture Substances 0.000 claims abstract description 32
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 15
- 230000007838 tissue remodeling Effects 0.000 claims abstract description 15
- 230000000699 topical effect Effects 0.000 claims abstract description 15
- 150000001875 compounds Chemical class 0.000 claims description 27
- 239000000284 extract Substances 0.000 claims description 15
- WSGCRSMLXFHGRM-DEVHWETNSA-N (2s)-2-[[(2s)-6-amino-2-[[(2s,3r)-2-[[(2s,3r)-2-[[(2s)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]-3-hydroxypropanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O WSGCRSMLXFHGRM-DEVHWETNSA-N 0.000 claims description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- 239000004020 conductor Substances 0.000 claims description 7
- 239000003981 vehicle Substances 0.000 claims description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
- BYUQATUKPXLFLZ-UIOOFZCWSA-N CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 Chemical compound CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 BYUQATUKPXLFLZ-UIOOFZCWSA-N 0.000 claims description 6
- 235000003500 Ruscus aculeatus Nutrition 0.000 claims description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 6
- 229940093441 palmitoyl oligopeptide Drugs 0.000 claims description 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 5
- 240000008669 Hedera helix Species 0.000 claims description 5
- 240000000353 Ruscus aculeatus Species 0.000 claims description 5
- 229960003160 hyaluronic acid Drugs 0.000 claims description 5
- IHRKJQSLKLYWBQ-QKDODKLFSA-N (2s)-2-[[(2s)-1-[(2s)-5-amino-2-[[2-(hexadecanoylamino)acetyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O IHRKJQSLKLYWBQ-QKDODKLFSA-N 0.000 claims description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 4
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 claims description 4
- QMQIQBOGXYYATH-IDABPMKMSA-N Ruscogenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)[C@H](O)C[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 QMQIQBOGXYYATH-IDABPMKMSA-N 0.000 claims description 4
- 239000001264 anethum graveolens Substances 0.000 claims description 4
- 239000001528 anethum graveolens l. herb oil Substances 0.000 claims description 4
- KDULJHFMZBRAHO-UHFFFAOYSA-N cioteronel Chemical compound C1C(=O)CC2C(CCCCC(CC)OC)CCC21 KDULJHFMZBRAHO-UHFFFAOYSA-N 0.000 claims description 4
- 229940119228 dill seed oil Drugs 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 229940094952 green tea extract Drugs 0.000 claims description 4
- 235000020688 green tea extract Nutrition 0.000 claims description 4
- 229940094946 palmitoyl tetrapeptide-7 Drugs 0.000 claims description 4
- 235000020334 white tea Nutrition 0.000 claims description 4
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 claims description 3
- 229930014124 (-)-epigallocatechin gallate Natural products 0.000 claims description 3
- NTWLPZMPTFQYQI-UHFFFAOYSA-N (3alpha)-olean-12-ene-3,23-diol Natural products C1CC(O)C(C)(CO)C2CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC3C21C NTWLPZMPTFQYQI-UHFFFAOYSA-N 0.000 claims description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 3
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 3
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 3
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 3
- GCGBHJLBFAPRDB-UHFFFAOYSA-N Hederagenin Natural products CC1(C)CCC2(CCC3(C)C4CCC5C(C)(CO)C(O)CCC5(C)C4CC=C3C2C1)C(=O)O GCGBHJLBFAPRDB-UHFFFAOYSA-N 0.000 claims description 3
- GCGBHJLBFAPRDB-KCVAUKQGSA-N Scutellaric acid Natural products CC1(C)CC[C@@]2(CC[C@@]3(C)[C@@H]4CC[C@H]5[C@@](C)(CO)[C@H](O)CC[C@]5(C)[C@H]4CC=C3[C@@H]2C1)C(=O)O GCGBHJLBFAPRDB-KCVAUKQGSA-N 0.000 claims description 3
- 229920002125 Sokalan® Polymers 0.000 claims description 3
- 229930003427 Vitamin E Natural products 0.000 claims description 3
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims description 3
- 229960001631 carbomer Drugs 0.000 claims description 3
- 229960000541 cetyl alcohol Drugs 0.000 claims description 3
- 239000003240 coconut oil Substances 0.000 claims description 3
- 235000019864 coconut oil Nutrition 0.000 claims description 3
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 3
- 229930003935 flavonoid Natural products 0.000 claims description 3
- 150000002215 flavonoids Chemical class 0.000 claims description 3
- 235000017173 flavonoids Nutrition 0.000 claims description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 3
- 229960002442 glucosamine Drugs 0.000 claims description 3
- 229940075529 glyceryl stearate Drugs 0.000 claims description 3
- PGOYMURMZNDHNS-MYPRUECHSA-N hederagenin Chemical compound C1C[C@H](O)[C@@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C PGOYMURMZNDHNS-MYPRUECHSA-N 0.000 claims description 3
- 229920003063 hydroxymethyl cellulose Polymers 0.000 claims description 3
- 229940031574 hydroxymethyl cellulose Drugs 0.000 claims description 3
- 229940119170 jojoba wax Drugs 0.000 claims description 3
- 239000004006 olive oil Substances 0.000 claims description 3
- 235000008390 olive oil Nutrition 0.000 claims description 3
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 3
- 239000004299 sodium benzoate Substances 0.000 claims description 3
- 235000010234 sodium benzoate Nutrition 0.000 claims description 3
- 235000019165 vitamin E Nutrition 0.000 claims description 3
- 229940046009 vitamin E Drugs 0.000 claims description 3
- 239000011709 vitamin E Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- BSUPFYRQXCQGLJ-UHFFFAOYSA-N Ruscogenin Natural products CC1CCC2(OC1)OC3C(O)C4C5CC=C6CC(O)CC(O)C6(C)C5CCC4(C)C3C2C BSUPFYRQXCQGLJ-UHFFFAOYSA-N 0.000 claims description 2
- QMQIQBOGXYYATH-UHFFFAOYSA-N epiruscogenin Natural products CC1C(C2(CCC3C4(C)C(O)CC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 QMQIQBOGXYYATH-UHFFFAOYSA-N 0.000 claims description 2
- 229940109990 ruscogenin Drugs 0.000 claims description 2
- 210000001519 tissue Anatomy 0.000 abstract description 80
- 108010014258 Elastin Proteins 0.000 abstract description 42
- 102000016942 Elastin Human genes 0.000 abstract description 40
- 229920002549 elastin Polymers 0.000 abstract description 40
- 210000004872 soft tissue Anatomy 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 15
- 230000008901 benefit Effects 0.000 abstract description 12
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 abstract description 10
- 229940099552 hyaluronan Drugs 0.000 abstract description 10
- 238000007920 subcutaneous administration Methods 0.000 abstract description 4
- 239000000126 substance Substances 0.000 description 23
- 210000003128 head Anatomy 0.000 description 19
- 230000015572 biosynthetic process Effects 0.000 description 12
- 239000000463 material Substances 0.000 description 12
- 230000015556 catabolic process Effects 0.000 description 10
- 238000006731 degradation reaction Methods 0.000 description 10
- 210000004177 elastic tissue Anatomy 0.000 description 10
- 239000011159 matrix material Substances 0.000 description 10
- 210000004556 brain Anatomy 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 7
- 241000282412 Homo Species 0.000 description 6
- 230000003292 diminished effect Effects 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 239000010985 leather Substances 0.000 description 6
- 230000000638 stimulation Effects 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 238000007906 compression Methods 0.000 description 5
- 230000006835 compression Effects 0.000 description 5
- 210000002808 connective tissue Anatomy 0.000 description 5
- 210000005069 ears Anatomy 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 230000007407 health benefit Effects 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 210000001011 carotid body Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 210000001724 microfibril Anatomy 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 230000004936 stimulating effect Effects 0.000 description 4
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 3
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 238000004873 anchoring Methods 0.000 description 3
- 210000001715 carotid artery Anatomy 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000005484 gravity Effects 0.000 description 3
- 235000010181 horse chestnut Nutrition 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 230000036651 mood Effects 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 238000007665 sagging Methods 0.000 description 3
- 230000008093 supporting effect Effects 0.000 description 3
- 230000003319 supportive effect Effects 0.000 description 3
- 241000157280 Aesculus hippocastanum Species 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102100033167 Elastin Human genes 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 208000000112 Myalgia Diseases 0.000 description 2
- 102000016387 Pancreatic elastase Human genes 0.000 description 2
- 108010067372 Pancreatic elastase Proteins 0.000 description 2
- -1 Polyethylene Polymers 0.000 description 2
- 206010041235 Snoring Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 238000007743 anodising Methods 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000008822 capillary blood flow Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 230000005672 electromagnetic field Effects 0.000 description 2
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 208000015001 muscle soreness Diseases 0.000 description 2
- 210000001989 nasopharynx Anatomy 0.000 description 2
- 210000004237 neck muscle Anatomy 0.000 description 2
- 208000001797 obstructive sleep apnea Diseases 0.000 description 2
- 210000004789 organ system Anatomy 0.000 description 2
- 210000003300 oropharynx Anatomy 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 238000007747 plating Methods 0.000 description 2
- 230000001144 postural effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000003625 skull Anatomy 0.000 description 2
- 230000002889 sympathetic effect Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 1
- KXGFMDJXCMQABM-UHFFFAOYSA-N 2-methoxy-6-methylphenol Chemical compound [CH]OC1=CC=CC([CH])=C1O KXGFMDJXCMQABM-UHFFFAOYSA-N 0.000 description 1
- GZSOSUNBTXMUFQ-NJGQXECBSA-N 5,7,3'-Trihydroxy-4'-methoxyflavone 7-O-rutinoside Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4cc(O)c(OC)cc4)Oc3c2)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 GZSOSUNBTXMUFQ-NJGQXECBSA-N 0.000 description 1
- 241000157282 Aesculus Species 0.000 description 1
- 229910000838 Al alloy Inorganic materials 0.000 description 1
- 229910000851 Alloy steel Inorganic materials 0.000 description 1
- 229920000049 Carbon (fiber) Polymers 0.000 description 1
- 229910000975 Carbon steel Inorganic materials 0.000 description 1
- 241000050051 Chelone glabra Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229910000881 Cu alloy Inorganic materials 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 241000235503 Glomus Species 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229910000861 Mg alloy Inorganic materials 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 229930182556 Polyacetal Natural products 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 206010043269 Tension headache Diseases 0.000 description 1
- 208000008548 Tension-Type Headache Diseases 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229910001315 Tool steel Inorganic materials 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229920006231 aramid fiber Polymers 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 238000000071 blow moulding Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 description 1
- 239000004917 carbon fiber Substances 0.000 description 1
- 239000010962 carbon steel Substances 0.000 description 1
- 210000001168 carotid artery common Anatomy 0.000 description 1
- 210000000269 carotid artery external Anatomy 0.000 description 1
- 210000004004 carotid artery internal Anatomy 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 230000003822 cell turnover Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 108091008690 chemoreceptors Proteins 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000005097 cold rolling Methods 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 208000027744 congestion Diseases 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- GZSOSUNBTXMUFQ-YFAPSIMESA-N diosmin Chemical compound C1=C(O)C(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 GZSOSUNBTXMUFQ-YFAPSIMESA-N 0.000 description 1
- 229960004352 diosmin Drugs 0.000 description 1
- IGBKNLGEMMEWKD-UHFFFAOYSA-N diosmin Natural products COc1ccc(cc1)C2=C(O)C(=O)c3c(O)cc(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 IGBKNLGEMMEWKD-UHFFFAOYSA-N 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 238000009429 electrical wiring Methods 0.000 description 1
- 238000003487 electrochemical reaction Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229940011399 escin Drugs 0.000 description 1
- 229930186222 escin Natural products 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 238000002676 facial rejuvenation Methods 0.000 description 1
- 239000011152 fibreglass Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 238000005242 forging Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940014041 hyaluronate Drugs 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 239000005414 inactive ingredient Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000013532 laser treatment Methods 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000037306 mature skin Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 210000000274 microglia Anatomy 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 239000002581 neurotoxin Substances 0.000 description 1
- 231100000618 neurotoxin Toxicity 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000001769 paralizing effect Effects 0.000 description 1
- 230000001734 parasympathetic effect Effects 0.000 description 1
- 210000001002 parasympathetic nervous system Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920001568 phenolic resin Polymers 0.000 description 1
- 239000005011 phenolic resin Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000272 proprioceptive effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000011506 response to oxidative stress Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 238000005488 sandblasting Methods 0.000 description 1
- 208000012672 seasonal affective disease Diseases 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000037075 skin appearance Effects 0.000 description 1
- 238000005476 soldering Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000008833 sun damage Effects 0.000 description 1
- 210000002820 sympathetic nervous system Anatomy 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000001721 transfer moulding Methods 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 238000007666 vacuum forming Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 210000000216 zygoma Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A45—HAND OR TRAVELLING ARTICLES
- A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
- A45D44/00—Other cosmetic or toiletry articles, e.g. for hairdressers' rooms
- A45D44/002—Masks for cosmetic treatment of the face
-
- A—HUMAN NECESSITIES
- A45—HAND OR TRAVELLING ARTICLES
- A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
- A45D44/00—Other cosmetic or toiletry articles, e.g. for hairdressers' rooms
- A45D44/22—Face shaping devices, e.g. chin straps; Wrinkle removers, e.g. stretching the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0212—Face masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
- A61M35/10—Wearable devices, e.g. garments, glasses or masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0216—Materials providing elastic properties, e.g. for facilitating deformation and avoid breaking
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/06—Head
- A61M2210/0606—Face
Definitions
- This invention relates to systems, devices and methods for facial remodeling. Specifically, embodiments of the invention relate to a system combining a device and topical tissue remodeling composition for toning skin and soft tissues of the face.
- moisturizers As the world's population ages, there is a demand for products and methods which may either delay the aging process or at least cause the skin, particularly of the face, to appear more youthful.
- products and methods which may either delay the aging process or at least cause the skin, particularly of the face, to appear more youthful.
- products There are literally thousands of products addressing this huge market including moisturizers, lotions, anti-aging creams and serums, cleansers and exfoliators to name just some. Many of these products are very expensive and provide only marginal benefit to the user. They may contain chemicals or substances directed to a specific action. For example, retinoids are utilized in anti-aging creams or serums as they increase cell turnover and may enhance collagen formation while moisturizers may contain glycerin and/or hyaluronic acid.
- Antioxidant creams may contain niacinamide or other substances that may help reduce the signs of sun damage while others contain substances that protect the skin from being damaged by the sun.
- Skincare products frequently contain multiple ingredients to address different issues, but almost uniformly they consist of substances that must be applied to the skin and absorbed into the epidermal and dermal layers of the skin. Despite the existence of very little evidence-based data that support the relative effectiveness of many of these compositions and methods, they are widely utilized as they are non-invasive, mostly safe, have limited side effects that usually can be corrected by discontinuing use, can be applied by the user, and gives the user the feeling that they are being proactive about their appearance.
- a treatment which combines a tissue remodeling composition or formulations of a self-applied topical skincare product with at least one other non-invasive modality having a physical effect on the tissues. Also missing from this array of skin treatments is a system combining a physical device configured to affect tissues and a topical composition that collectively work together to enhance the individual effect of one another in a non-invasive manner.
- Embodiments of the present invention include a mask device for grounding tissues of the face combined with a topical tissue remodeling composition.
- a system of facial remodeling comprising a facial mask having a first lifting strap; a tissue remodeling composition, wherein the facial mask is configured to support a facial tissue treated with the tissue remodeling composition.
- the facial mask comprises a grounding member coupled to the first lifting strap. In some embodiments, the facial mask comprises an ear section coupled to the first lifting strap; and a second lifting strap coupled to the ear section, wherein the first lifting strap and the second lifting strap are coupled together by the ear section.
- the facial mask comprises a grounding member coupled to the facial mask. In some embodiments, the facial mask comprises a grounding member coupled to the second lifting strap.
- the facial mask comprises an elastomeric element. In some embodiments, the first lifting strap comprises an elastomeric element.
- the remodeling composition comprises an elastin-promoting compound; a hyaluronan-promoting compound; and a topical delivery vehicle.
- the elastin-promoting compound is at least one compound selected from the group of compounds consisting of: a ruscogenin at a concentration in a range between about 0.5 percent and 3.0 percent; a dill seed extract at a concentration in a range between about 1 percent and about 5 percent; and a dill seed oil at a concentration in a range between about 1 percent and 5 percent.
- the elastin-promoting compound is selected from the group of elastin-promoting compounds consisting of: Ruscus aculeatus extract; epigallocatechin-3-gallate; white tea extract; green tea extract; micronized purified flavonoid fraction; Hedera helix extract; hederagenin; palmitoyl pentapeptide-4; palmitoyl oligopeptide; and palmitoyl-tetrapeptide-7.
- the hyaluronan-promoting compound is selected from the group of hyaluronan-promoting compounds consisting of: glucosamine, palmitoyl pentapeptide-4; palmitoyl oligopeptide; palomitoyl-tetrapeptide-7; and ethoxyheptyl bicyclooctanone.
- the topical delivery vehicle is selected from the group of topical delivery vehicles consisting of: water; glycerin; cetyl alcohol; coconut oil; olive oil; jojoba oil; glyceryl stearate; a paraben; sodium benzoate; vitamin E; hydroxymethyl cellulose; hyaluronic acid; propylene glycol; disodium EDTA; and a carbomer.
- a facial mask comprising a first lifting strap; a grounding means; and a compression means.
- the facial mask comprises a second lifting strap coupled to the first lifting strap.
- the first lifting strap is configured to support a skin tissue overlying a zygomatic eminence.
- the second lifting strap is configured to support a skin tissue overlying a neck region.
- a method of facial remodeling comprising steps applying a topical tissue remodeling composition to skin; and donning a facial mask.
- the method further comprises a grounding step, wherein the facial mask is grounded to a grounding means. In some embodiments, the method further comprises a biasing step, wherein the facial mask biases a facial soft tissue in a cranial direction. In some embodiments, the method further comprises a compressing step, wherein a facial soft tissue is compressed.
- FIG. 1 a side perspective view of a facial mask worn by a user
- FIG. 2 is a front perspective view of a facial mask worn by a user
- FIG. 3 is an additional front perspective view of a facial mask worn by a user
- FIG. 4 is a front perspective view of a facial mask worn by a user
- FIG. 5 is a perspective view of an attachment means for a facial mask.
- FIG. 6 is a flowchart of a method of forming a system of facial remodeling.
- the foregoing application describes a system, device, and methods of use for facial remodeling.
- the system employs a facial mask for compressing and supporting facial tissues in conjunction with a composition to promote restoration of elastin and hyaluronan, provided with a delivery vehicle in a topical preparation.
- a facial mask which, in some embodiments, includes combinations of different elements and configurations for compressing skin and underlying soft tissue, cranially biasing areas of skin and soft tissue, and grounding the face, head, and neck tissues.
- Elastin is a highly elastic protein that coils and recoils similar to a spring within the elastic fibers of skin and connective tissue and is mostly responsible for the elasticity of structures. It functions in tissues with collagen. As one grows older, elastin production diminishes as elastin degradation accelerates. Combined with gravity, many tissues, including facial skin and tissue, begin to sag in a continual process as the tissue is unable to regain or rebound to the youthful appearing shape over years of stretching and contracting.
- Some embodiments comprise a device configured to support facial tissues while the substance(s) is being absorbed into the tissues.
- Some embodiments of the present invention comprise a substance or substances which stimulate elastin production, prevent elastin degradation, or both. Hence, if the elastin fibers are stimulated or protected while the tissues containing them are being maintained in a non-stretched condition, skin and tissue elasticity will be enhanced.
- the term “lifting” means biasing an area of skin, or an area of skin and soft connective tissue underlying the skin, in a cranial direction. This is independent of whether the user is sitting or standing, wherein the cranial direction is “up.” Lifting/biasing skin and soft tissue is caused to happen in a cranial direction independent of orientation of the face, whether the user is supine, sitting, standing, or in any other position.
- “Cranial” is an anatomic relational term meaning towards the top of the head. It is the opposite of “caudal,” meaning towards the feet. Cranial, therefore, means towards the head and away from the feet.
- the device is a facial mask comprising a first lifting strap that elevates the cheek tissues and is secured to the face by one of several means configured to removably attach the facial mask to the face.
- the facial mask device comprises a second lifting strap that supports the tissues beneath the chin, the jowls, the periorbital tissues or other tissues as well.
- the facial mask may be constructed of any number of materials, but preferably the mask comprises an elastic component to bias facial skin and tissue upward—toward the scalp—under a condition wherein the mask is secured to the user's head.
- Utilization of this system of elastin stimulating or protective/reparative substances along with a physical lifting means to support the tissues while the substance(s) are acting may be done while the user is sleeping, wherein there is a prolonged period of combined physical support and tissue lifting with elastin stimulation and/or protection/repair.
- Substances that may be utilized with the facial mask device to enhance elastin production or repair and stabilize existing elastin and substances which may enhance the production or repair and stabilize hyaluronan may employ 1) the physical lifting of tissues by a supportive lifting strap, 2) substances to enhance production of critical components of a facial tissue and/or inhibit their degradation, and 3) the healing and capillary blood flow enhancing features of grounding the facial tissues.
- a method of firming and tightening mature skin may involve achieving an increase in the skin content of [primarily] elastin and [secondarily] hyaluronan (aka hyaluronate, hyaluronic acid), both of which decline with age. It involves (1) synergistic stimulation of elastin synthesis and inhibition of elastin degradation, and (2) synergistic stimulation of hyaluronan synthesis with inhibition of hyaluronan degradation.
- the formation of elastic fibers in the skin consists of several stages that include (1) the production of tropoelastin by fibroblasts, (2) enzymatic crosslinking of tropoelastin yielding elastic microfibrils, (3) microfibril assembly and elastin accretion and, finally, (4) development, anchoring and maturation of elastic fiber that becomes an integral part of the skin matrix.
- This process occurs in the spatial context of the skin matrix consisting of a variety of biopolymers and structures influencing all of the above steps, but especially steps 3 and 4.
- the skin matrix provides a grid guiding microfibril assembly and anchoring of the developing elastic fibers, thus affecting their eventual spatial positioning in the skin.
- the physical state of the skin matrix during the formation of new elastic fibers affects the position and ultimate effect of the newly developed fibers on the skin.
- the elastic fiber will be deposited and anchored in such a way as to stabilize the more compressed state of the skin matrix, yielding a greater skin tightening effect.
- Compressing the skin matrix during elastic fiber development provides an opportunity to combine stimulation of elastin synthesis with skin matrix compression via mechanical soft tissue lifting. Simply put, stimulating the formation of elastin while the tissues are supported, or compressed in a lifted, non-stretched configuration, will improve the elastic properties of the skin particularly by enhancing the elastin assembly, placement, and anchoring on the microfibrils so that the resulting elastic fibers have more lifting ability than if they were formed or repaired while stretched out in a non-supported elongated configuration. Degraded elastin is comparable to a metal spring which has been stretched for years with the resultant elongation and loss of its ability to contract back into a spiral, spring like configuration.
- Repairing the spring's elasticity by heat treating the metal of spring may involve compressing the spring prior to the heat treatment to restore the original shape of the spring.
- the lifting means of the current invention supports or compresses upward the tissues of at least one part of the facial tissues so that at least one of the repair or stimulation of the synthesis of elastin and elastic fibers may result in a greater skin tightening effect which reduces the sagging of skin and tissues.
- Increasing the amount of elastin in the skin may be achieved by using a topically applied formulation containing agent(s) that increase the biosynthesis of elastin, such as, but not limited to, aqueous dill seed extract and/or dill seed oil and ethoxyheptyl bicyclooctanone and agent(s) that decrease degradation of elastin either by directly inhibiting elastase and related matrix metalloproteinases (MMP-s), such as, but not limited to, extract of Ruscus aculeatus (aka butchers broom) or purified ruscogenins isolated from Ruscus aculeatus and Epigallocatechin-3-gallate (EGCG).
- MMP-s matrix metalloproteinases
- Other substances that act by shielding elastin from contact with elastase and related MMPs include white tea extract, Green tea extract, micronized purified flavonoid fraction (MPFF) (diosmin+hesperidin), Extract of Hedera helix (a.k.a. common ivy) or purified hederagenin isolated from Hedera helix , skin matrix derived/related peptides, such as palmitoyl pentapeptide-4 (MATRIXYL) and palmitoyl oligopeptide & palmitoyl-tetrapeptide-7 (MATRIXYL 3000).
- MMPFF micronized purified flavonoid fraction
- Increase in the hyaluronan skin content is achieved by using a topically applied formulation containing agent(s) that increase the biosynthesis of hyaluronan and may include glucosamine, skin matrix derived or related peptides, such as palmitoyl pentapeptide-4 (MATRIXYL) and palmitoyl oligopeptide & palmitoyl-tetrapeptide-7 (MATRIXYL 3000), and ethoxyheptyl bicyclooctanone, among others.
- agent(s) that increase the biosynthesis of hyaluronan and may include glucosamine, skin matrix derived or related peptides, such as palmitoyl pentapeptide-4 (MATRIXYL) and palmitoyl oligopeptide & palmitoyl-tetrapeptide-7 (MATRIXYL 3000), and ethoxyheptyl bicyclooctanone, among others.
- Agents that decrease degradation of hyaluronan may include Extract of Aesculus hippocastanum (a.k.a. horse chestnut) or escin isolated from Aesculus hippocastanum and MPFF, among others.
- tissue remodeling composition is utilized with the supportive lifting strap and/or grounding.
- the composition comprises active ingredients including: either ruscogenins at a concentration of between about 0.5% and 3.0% or an equivalent amount of Ruscus aculeatus extract; a dill seed extract at a concentration of between about 1.0% and 5.0%; a dill seed oil at a concentration of between about 1.0% and 5.0%; and either an EGCG at a concentration of between about 1.0% and 5.0% or an equivalent amount of white/green tea extract.
- active ingredients including: either ruscogenins at a concentration of between about 0.5% and 3.0% or an equivalent amount of Ruscus aculeatus extract; a dill seed extract at a concentration of between about 1.0% and 5.0%; a dill seed oil at a concentration of between about 1.0% and 5.0%; and either an EGCG at a concentration of between about 1.0% and 5.0% or an equivalent amount of white/green tea extract.
- the composition comprises inactive ingredients including: water; a glycerin; a cetyl alcohol; a coconut oil; an olive oil; a jojoba oil; a glyceryl stearate; a paraben such as a methyl paraben, an ethyl paraben, or a poly paraben; a sodium benzoate, a vitamin E, a hydroxymethyl cellulose, a hyaluronic acid, a propylene glycol, a disodium EDTA, and a carbomer.
- inactive ingredients including: water; a glycerin; a cetyl alcohol; a coconut oil; an olive oil; a jojoba oil; a glyceryl stearate; a paraben such as a methyl paraben, an ethyl paraben, or a poly paraben; a sodium benzoate, a vitamin E, a hydroxymethyl cellulose, a hyalur
- some embodiments include other physical means to provide electric currents to promote transcutaneous absorption of the composition.
- the first lifting strap, the second lifting strap, or both the first lifting strap and the second lifting strap are configured to provide electric currents.
- the electric currents are micro-currents and are generated by a battery or similar current-providing means.
- the current-providing means in some embodiments, is incorporated within or coupled to the facial mask.
- a separate current-providing means is electrically coupled to elements of the facial mask.
- a natural passive current is provided by a grounding means.
- grounding means When grounding means are utilized, they may be connected to a grounding member that is connected to the earth via grounded wires directly into the earth or indirectly via the grounded receptacle of a standard electrical outlet.
- the facial mask may comprise electrically conductive materials or means within the facial mask without a grounding member attached to the facial mask. In this case, the conductive materials may contact second or subsequent conductive means that is connected to a grounded cord such as, but not limited to, a grounded pillow case or grounded pillow case insert which may be connected to a grounding member to the earth directly or indirectly.
- the facial tissues may be conductively connected to the conductive facial mask which in turn is conductively connected to a pillow case, pad, or other means by physical approximation or touching of the facial mask and the pillow case or other means, and the pillow case or other means are then connected to the ground source by a grounding wire,
- the user will not experience the “tethering” effect of being directly connected to a grounding member and may experience more comfort and freedom of movement while sleeping.
- this latter configuration will allow the user to arise from bed, or from wherever they may be, without having to detach or uncouple the grounding member or means from the mask. They may then return and become grounded again by simply placing their head on the pillow case or other secondary grounding means.
- Grounding is a term that describes efforts to achieve health benefits from walking outside while barefoot or while wearing electrically conductive footwear such as leather, or when performing indoor activities (working, sleeping, etc.) while connected to conductive systems that transfer the Earth's electrons from the ground via a ground wire or other conductive means into the body.
- Reported health benefits include stabilization of the immune system, enhanced heart rate variability, enhanced healing, diminished inflammation, normalized blood pressure, diminished cortisol levels, improved mood, diminished delayed onset muscle soreness after strenuous exercise, increased capillary blood flow and protection against dementia, amongst many other health benefits.
- grounding devices act by grounding the user with a sheet to sleep upon, pads, straps, or adhesive electrodes that are connected to the ground via wires or through the ground terminal of an electrical outlet. While these means may help with restoring our natural neutral electric potential, humans have connected with the ground mostly through their feet while awake sixteen hours a day. They slept on nonconductive cellulose in the form of dried leaves, straw, and other nonconductive plant material to cushion them from the earth. Hence, although grounding during sleep may have some benefits, it does not mimic the evolution of humans being primarily grounded while awake and primarily through the feet when awake. We evolved by being grounded primarily through channels which originate in the soles of our feet.
- leather is somewhat conductive, and humans have used animal skins for footwear for eons. Especially with a bit of moisture from the environment or just from perspiration on the soles of the feet or both, footwear of leather and other animal products provides enough electrical conductivity to adequate ground the wearer. However, since leather does not provide complete dryness, becomes wet, is expensive, and is difficult to configure a traction tread, amongst other drawbacks, the vast majority of footwear utilizes other non-conductive man-made materials at least for the sole. This essentially insulates the user from the earth and the many readily encountered conductive substances covering the earth and prevents the ingress of beneficial electrons into the body.
- One's overall appearance does reflect one's overall health and well-being including one's psychological condition, immune system, sympathetic/parasympathetic nervous system balance, mood, and many other conditions that may be improved by grounding.
- This means of grounding is especially important as our natural means of connecting with the earth through our feet has been severely limited, if not eliminated, over the past 50 years because of non-conductive footwear.
- grounding device that provides grounding benefits while sleeping and promotes facial rejuvenation, vitality, mental clarity, diminished anxiety, and health is described.
- One embodiment of this device is constructed to be worn while in bed, driving a car, or during sitting while at a computer workstation, amongst others.
- the device is electrically coupled to the earth by wires and a grounding rod placed in the earth or by a connection, which are be wires, in some embodiments; to the ground terminal or a third hole of an electrical outlet.
- the grounding device extends over a portion of the face and is anchored over the ears and then cinched beneath the chin to secure it.
- the grounding device is secured about the dorsal aspect of the head. Benefits provided by the grounding device include increased vascularity and healing to the facial tissues, focused grounding to the head and neck region including the brain, diminished snoring and obstructive sleep apnea, and others.
- grounding one particular body part has been shown to be effective throughout the whole body, grounding closer to the area of desired effect has also been shown to be more effective when a specific outcome is desired or when the effects of grounding are desired to be maximized at a particular anatomical area. This has been documented by the inventor with different experiments and practiced by others. For example, to relieve or prevent delayed onset muscle soreness, some practitioners place a grounding electrode over the particular muscle group of interest rather than using a pad to sleep upon or a grounding electrode on one foot. Moreover, by utilizing an inexpensive voltmeter, one can easily determine that the voltage in the part of the body closest to the grounding source diminishes more than the voltage at the remote location.
- one strategy may be to place the grounding source closer to those areas than simply having a grounding contact on an extremity or in contact with the torso.
- This device may have a more localized and focally greater grounding effect on the delicate tissues of the face and neck, the sinuses and nasopharynx, the oropharynx, scalp and neck muscles, the brain and other head and neck structures than a remote grounding location.
- This observation may be validated by the Inverse Square Law, which states that the intensity of a physical quantity is inversely proportional to the square of the distance from the source of that physical quantity.
- the benefits of grounding are focally delivered by the grounding device to the important facial structures to improve appearance; to the sinuses, nasopharynx and oropharynx to combat congestion, obstructive sleep apnea, and snoring; to the scalp and neck muscles to combat tension headaches and tension in general; to the ears to enhance hearing and diminish tinnitus; and to the brain to provide a host of positive benefits including better sleep, improved mood, augmented immune response, diminished seasonal affective disorder, and increased energy, amongst many other health benefits.
- These benefits may be provided directly to the head and neck area, but will positively affect other more remote areas of the body as well.
- the grounding device comprises a grounded skull cap.
- the thick bone of the skull may not be as conductive as the soft tissues of the face and neck and the rather delicate bony structures at the base of the skull. Hence placing the grounding device over the very vascular facial structures and over the arteries of the neck may be more effective at grounding the tissues of the brain and head and neck.
- the facial mask, the first lifting strap, or the second lifting strap comprises a grounding surface electrically coupled to the skin of at least some of the user's face as well as the head and neck structures.
- a grounding surface is on the middle one third of the user's face below the eyes and is anchored or held in place by a retention means placed over or around the ears or behind the head.
- a grounding member is electrically coupled to the grounding device.
- the grounding device is electrically coupled to a second grounding device or alternative electrically conductive object that is primarily or secondarily grounded, such as a pillow case or mat which contacts the grounding device.
- the facial mask extends to the upper neck and/or chin to contact the skin in the submandibular region.
- the grounding device is positioned over the carotid arteries located anteriorly in the upper neck region. These arteries carry blood and electrical charges to the brain where inflammation has been shown to cause a number of health issues, including immune disorders, depression, anxiety, and a host of others. In fact, upregulation of the microglia of the brain is an important central inflammatory reaction which may be at the root of many more chronic and even acute illnesses and conditions. The anti-inflammatory properties of grounding hence may be concentrated in the head and neck region wherein the grounding device provides focal grounding in the head and neck region.
- grounding device lifting the tissues of the cheeks or other tissues while in place and providing the grounding benefits, as in the facial mask described herein.
- Supporting facial structures may cause the user to have a more youthful appearance as the combined effects of grounding and support provide a more refreshed skin appearance with less sagging of the facial tissues which may occur with normal aging.
- grounding, lifting support, and elastin stimulation/reparation are provided simultaneously. If the facial mask is utilized only during sleep, the uplifting of the facial tissues may not completely persist through the day as gravity will cause the tissues to sag towards their original position when the individual is erect. However, human tissue has somewhat of a memory and some of the lifting of the tissues will persist despite the effects of gravity when not using the facial mask. This is especially true with repeated use. If one uses the facial mask only during sleep for 7 hours a night, that computes to 49 hours each week, 210 hours each month, and 2,555 hours each year. This also equates to slightly less than 1 ⁇ 3 of one's existence.
- This time is enough to effect substantive change in the skin, subcutaneous tissues, connective tissues, etc., that may result in an improved appearance especially when combined with either a elastin stimulating or reparative substance or the focal anti-inflammatory effects of focal grounding on the tissues of the head and neck or both.
- the facial mask is formed in one of several configurations, according to the embodiment of the invention.
- the supportive facial mask comprises the first lifting strap and the grounding device that conductively contacts the tissues of at least one of the face and neck.
- Some embodiments of the facial remodeling system comprise the grounding device. Some embodiments of the facial remodeling system do not comprise the grounding device.
- FIG. 1 is a side perspective view of a facial mask worn by a user.
- FIG. 1 shows facial mask 120 with grounding device is configured as the first lifting strap, the second lifting strap, or an additional strap configured to support the facial skin and tissue.
- FIG. 1 which is a partial side view of a face of a subject and the instant invention, a facial mask 120 , which comprises a nose to ear portion forming a first lifting strap 121 , an upper neck portion forming a second lifting strap 122 , an ear section 123 coupled between first lifting strap 121 and second lifting strap 122 , a central portion 124 coupled between two first lifting straps 121 , a first securing means 125 configured to couple a grounding member 126 to second lifting strap 122 , as shown in FIG. 1 .
- First lifting strap (nose to ear portion) 121 in some embodiments, is not straight but rather comprises a downward or caudal-directed convex curve and contacts the skin of the cheek tissues below a zygomatic eminence (cheek bone) 127 .
- First lifting strap 121 (nose to ear portion 121 ), in some embodiments, is formed from an elastomer and configured to lift the cheek tissues when worn.
- the lower or caudal portion of first lifting strap (nose to ear portion) 121 is reinforced so that it compressively lifts the tissue, in some embodiments.
- first lifting strap (nose to ear portion) 121 is be more lax than the lower or caudal portion so that it does not compress the tissue that is being compressively lifted by the lower or caudal portion, in some embodiments.
- central portion 124 is not elastic at all so as to prevent elevation of the lower lip. A non-elastic central portion 124 may not cause any traction on the upper lip when the entire device is worn, which is a desired action.
- the means to secure the lifting strap means to the face comprises first securing means 125 positioned under the chin after being secured over the ears or may comprise a different securing mechanism which may extend to and be secured about the dorsal aspect of the head.
- FIG. 2 is a front perspective view of a facial mask worn by a user.
- FIG. 2 shows facial mask 120 worn on the user's face.
- facial mask 120 is configured such that first lifting strap 121 , second lifting strap 122 , or both first lifting strap 121 and second lifting strap 122 are positioned below the area of the cheeks.
- a curved configuration of first lifting strap (nose to ear portion) 121 of facial mask 120 is configured, as shown by FIG. 2 and in some other embodiments, to accommodate this, as a straight strap or straight nose to ear portion would traverse the cheeks and compress them rather than supporting them. Accordingly, a first width of first lifting strap (nose to ear portion) 121 must be adequate to support the tissues without creating a furrow in the skin of the face.
- the first width is in a range of from about 2 millimeters (mm) to about 10 centimeters (cm). In some embodiments, the first width is between about 2.0 cm and about 5.0 cm.
- Some or all elements of facial mask 120 may comprise an elastomeric element, but particularly first lifting strap (nose to ear portion) 121 . The elastomeric element(s) may be placed elsewhere however. Elasticity combined with the downward curvature of first lifting strap (nose to ear portion) 121 tend, in some embodiments, to lift the cheek tissues.
- Grounding may be provided or may not be provided.
- facial mask 102 is grounded by one of several means, including but not limited to utilizing an electrically conductive material for the entire facial mask 120 , utilizing conductive materials to connect different conductive materials at different locations within facial mask 120 to the grounding source, utilizing a conductive material which is added to the non-conductive facial mask to provide grounding, or other means.
- focal grounding may be provided in specific areas and not throughout facial mask 120 .
- conductive means may be provided only in first lifting strap (nose to ear portion) 121 where the facial tissues are supported, over the carotid arteries in second lifting strap (neck portion) 122 to deliver focal grounding over the blood supply to the brain, over the upper lip to combat the aging of tissues in that location, or the like.
- Focal grounding in the mid-neck over the carotid arteries may be of particular importance as the carotid body mechanism (carotid glomus or glomus caroticum), is located at the branching of the common carotid artery into the internal carotid artery and external carotid artery.
- the carotid body contains specialized cells and a rich network of chemoreceptors and nerve fibers that control many body functions including oxygen, carbon dioxide and hydrogen ion regulation, respiration, heart beat and rhythm, multiple sympathetic and parasympathetic functions, amongst others.
- a conductive means may be provided to target only certain anatomical locations or several anatomical locations concurrently.
- FIG. 3 is an additional front perspective view of a facial mask worn by a user.
- FIG. 3 demonstrates a partial frontal view of an alternative embodiment of facial mask 120 .
- first lifting strap 121 comprises a first part 130 coupled to a second part 131 .
- First part 130 in some embodiments, is configured to simultaneously support and ground.
- first part 130 is configured to support.
- second part 131 is configured to ground without giving support or significant compression but with contact of the tissues of the cheek area wherein the configuration will provide focal grounding to the skin and tissues of the cheeks without compressing the cheek tissues as first part 130 of first lifting strap 121 delivers support and lifting of the cheek tissues.
- FIG. 4 is a front perspective view of a facial mask worn by a user.
- FIG. 4 shows an alternative embodiment of facial mask 120 , provide means to support with or without focally grounding to the tissues of the upper neck.
- Second lifting strap 122 of facial mask 120 is configured to contact an increased surface area of skin of the upper neck.
- second lifting strap 122 comprises a third part 132 , as shown by FIG. 4 .
- Third part 132 may provide grounding, support, or compression to additional tissues, including the submandibular tissues where jowls develop, turkey neck occurs, and crepe like skin is common.
- Third part 132 is comprised by facial mask 120 having any one or combination of elements listed herein.
- the combination of focal grounding and compression with a composition to stimulate elastin and other components or diminish the degradation of elastin and other components of tissues, along with providing structural physical support for these delicate tissues is configured to work harmoniously to reduce and at least partially correct the oxidative stress reactions in the tissues which result in the aging changes and to at least partially re-mold the tissues to a more youthful appearance.
- FIG. 5 is a perspective view of an attachment means for a facial mask.
- the embodiments described herein may be secured to the user by the example means shown above or by other alternative means or configurations including, but not limited to, the configuration in FIG. 5 .
- FIG. 5 shows a second securing means 128 configured to secure the first lifting strap 121 to the head and to provide upward lifting of the tissues of the cheeks at the same time.
- Facial mask 120 is configured to only provide focal grounding without providing any structural support to the soft tissues. Facial mask 120 may or may not be grounded, according to the embodiment of the invention.
- Grounding member 126 (See FIGS. 1, 2 , & 4 ), if comprised by the embodiment, is electrically coupled to second securing means 128 of facial mask 120 .
- grounding member 126 is electrically coupled to a grounded body, such as a pad or pillow case, by simple physical contact with that grounded body.
- Grounding member 126 is also electrically coupled to any grounding means, many examples of which are discussed
- the components defining any system and device for facial remodeling may be formed of any of many different types of materials or combinations thereof that can readily be formed into shaped objects provided that the components selected are consistent with the intended operation of a system and device for facial remodeling.
- the components may be formed of: rubbers (synthetic and/or natural) and/or other like materials; glasses (such as fiberglass) carbon-fiber, aramid-fiber, any combination thereof, and/or other like materials; polymers such as thermoplastics (such as ABS, Fluoropolymers, Polyacetal, Polyamide; Polycarbonate, Polyethylene, Polysulfone, and/or the like), thermosets (such as Epoxy, Phenolic Resin, Polyimide, Polyurethane, Silicone, and/or the like), any combination thereof, and/or other like materials; composites and/or other like materials; metals, such as zinc, magnesium, titanium, copper, iron, steel, carbon steel, alloy steel, tool steel, stainless steel, aluminum, any combination thereof, and/or other like materials; alloys,
- any system and device for facial remodeling may be purchased pre-manufactured or manufactured separately and then assembled together.
- any or all of the components may be manufactured simultaneously and integrally joined with one another.
- Manufacture of these components separately or simultaneously may involve extrusion, pultrusion, vacuum forming, injection molding, blow molding, resin transfer molding, casting, forging, cold rolling, milling, drilling, reaming, turning, grinding, stamping, cutting, bending, welding, soldering, hardening, riveting, punching, plating, and/or the like.
- any of the components are manufactured separately, they may then be coupled with one another in any manner, such as with adhesive, a weld, annealing, a fastener (e.g.
- Other possible steps might include sand blasting, polishing, powder coating, zinc plating, anodizing, hard anodizing, and/or painting the components for example.
- FIG. 6 is a flowchart of a method of using a system and device for facial remodeling.
- FIG. 6 shows a method 200 comprising an applying step 210 , a donning step 220 , a grounding step 230 , a biasing step 240 , and a compressing step 250 .
- Applying step 210 comprises applying a topical tissue remodeling composition to skin.
- the composition comprises an elastin-enhancing compound.
- the composition comprises a plurality of elastin-enhancing compounds.
- An elastin-enhancing compound is a compound or mixture of compounds known or used to either inhibit elastin degradation in a tissue, such as a skin tissue or a subcutaneous connective tissue, or to promote elastin synthesis in a skin tissue of a subcutaneous connective tissue.
- the compound may be a currently known compound, or a compound discovered at some future time to inhibit elastin degradation, promote elastin synthesis, or both.
- Donning step 220 comprises donning a facial mask.
- donning step 220 comprises looping an ear section over each of the user's ears, causing a first lifting strap coupled to the ear section on each side of the user's face to contact an area of skin of the user's face.
- the area of skin includes skin overlying the zygomatic eminence.
- donning step 220 comprises applying a second lifting strap on each side of the user's face or neck to contact an area of skin of the user's face or neck.
- Grounding step 230 comprises grounding the facial mask to a grounding means. In some embodiments, grounding step 230 comprises coupling a grounding member to the facial mask. In some embodiments, grounding step 230 comprises coupling the grounding member to the first lifting strap. It is understood that the grounding member is grounded by any suitable grounding means discussed herein, wherein the grounding member is electrically coupled, or “earthed,” to the ground. Some embodiments of method 200 do not comprise grounding step 230 .
- Biasing step 240 comprises biasing a facial soft tissue in a cranial direction.
- biasing step 240 is caused by an elastomeric member comprising the facial mask, such as an elastomeric first lifting strap or an elastomeric second lifting strap, for example.
- Compressing step 250 comprises compressing a facial soft tissue. Similar to biasing step 240 , in some embodiments, compressing step 250 is causes by an elastomeric member comprises the facial mask, or some element of the facial mask, as discussed herein. Some embodiments, of method 200 do not comprise compressing step 250 .
- a system, device, and method of facial remodeling are disclosed.
- the system combines a topical composition configured to restore elastin, hyaluronan, or both to the skin and subcutaneous soft tissues of the face and neck combined with a facial mask to support and, in some embodiment, compress the tissue, to enhance and preserve the tissue remodeling effects of the composition.
- the device and method include a means for electrically grounding—“earthing”—the skin and soft tissues of the face, neck, and head.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims (15)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/863,174 US11109661B2 (en) | 2016-07-26 | 2018-01-05 | System, device and method of facial remodeling |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662366891P | 2016-07-26 | 2016-07-26 | |
US201762443985P | 2017-01-09 | 2017-01-09 | |
US15/660,809 US20180028116A1 (en) | 2016-07-26 | 2017-07-26 | Proprioceptive enhancement device and method of use |
US15/863,174 US11109661B2 (en) | 2016-07-26 | 2018-01-05 | System, device and method of facial remodeling |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/660,809 Continuation-In-Part US20180028116A1 (en) | 2016-07-26 | 2017-07-26 | Proprioceptive enhancement device and method of use |
Publications (2)
Publication Number | Publication Date |
---|---|
US20180125205A1 US20180125205A1 (en) | 2018-05-10 |
US11109661B2 true US11109661B2 (en) | 2021-09-07 |
Family
ID=62065552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/863,174 Active US11109661B2 (en) | 2016-07-26 | 2018-01-05 | System, device and method of facial remodeling |
Country Status (1)
Country | Link |
---|---|
US (1) | US11109661B2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109793338B (en) * | 2018-12-21 | 2021-09-24 | 刘维维 | Facial muscle lifting and shaping device |
CN110664635B (en) * | 2019-11-05 | 2021-05-07 | 湖北创界生物科技有限公司 | Moisturizing and hydrating mask composition, mask and preparation method of mask |
Citations (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB191107396A (en) * | 1910-03-28 | 1911-10-05 | Eugene Joseph Mccarthy | Massaging Apparatus. |
US1678970A (en) * | 1926-11-05 | 1928-07-31 | Arlen Olga Louise | Facial bandage |
US2728339A (en) * | 1954-09-10 | 1955-12-27 | Elmhirst Kathleen | Facial mask |
US4150418A (en) | 1977-08-12 | 1979-04-17 | Charleswater Products, Inc. | Electrically conductive footwear |
US4201433A (en) * | 1978-07-06 | 1980-05-06 | Fargo Manufacturing Company, Inc. | Grounding connector |
US4249226A (en) | 1979-02-22 | 1981-02-03 | Minnesota Mining And Manufacturing Company | Grounding strap |
US4642912A (en) | 1984-05-02 | 1987-02-17 | Scholl, Inc. | Shoe insole |
US4926570A (en) | 1987-07-22 | 1990-05-22 | Lohmann Gmbh & Co. Kg | Shoe inner sole, particularly insole or welt |
US5004425A (en) | 1989-10-10 | 1991-04-02 | Jes, L.P. | Magnetic snap assembly for connecting grounding cord to electrically conductive body band |
US5091996A (en) * | 1989-03-13 | 1992-03-03 | Kirby Richard C | Face mask |
US5233769A (en) | 1990-07-17 | 1993-08-10 | Spenco Medical Corporation | Electrically conductive shoe insole |
US5576924A (en) | 1995-07-31 | 1996-11-19 | Hee; Roland | Heel grounding device |
US5599546A (en) | 1992-06-16 | 1997-02-04 | Klein; Marvin E. | Medicinal facial mask |
US5935596A (en) | 1997-03-20 | 1999-08-10 | Chesebrough-Pond's Usa Co. | Delivery of skin benefit agents via adhesive strips |
US6003247A (en) | 1997-05-23 | 1999-12-21 | Steffe; Daniel D. | Anti-static boot having a conductive upper |
US6237256B1 (en) | 1998-08-12 | 2001-05-29 | Sunnybrook And Women's College Health Sciences Centre | Balance-enhanced insert for footwear |
KR20010094548A (en) * | 2000-03-31 | 2001-11-01 | 유상옥,송운한 | Skin Care Cosmetic Composition |
US6682779B1 (en) | 1999-09-24 | 2004-01-27 | Henkel Kommanditgesellschaft Auf Aktien | Coating means for elastomers |
US6707659B2 (en) | 2002-06-18 | 2004-03-16 | Roland Hee | Heel grounder |
US20040161435A1 (en) | 2003-02-14 | 2004-08-19 | Gupta Shyam K. | Skin Firming Anti-Aging Cosmetic Mask Compositions |
US20040173220A1 (en) | 2003-03-06 | 2004-09-09 | Harry Jason D. | Method and apparatus for improving human balance and gait and preventing foot injury |
US20040219124A1 (en) | 2003-05-01 | 2004-11-04 | Gupta Shyam K. | Cosmetic and Pharmaceutical Masks Based on Ion-Pair Delivery System |
US7055266B2 (en) | 2002-04-01 | 2006-06-06 | Wayne Elsey | Electrostatically dissipative athletic shoe |
US7212392B2 (en) | 2005-06-15 | 2007-05-01 | Earth Fx | Personal body grounding system instrumentation and process |
US20090130040A1 (en) | 2006-04-14 | 2009-05-21 | Lvmh Recherche | Cosmetic rinsable mask type composition for skin care |
US7609503B2 (en) | 2007-11-12 | 2009-10-27 | Roland Hee | Insulated metal grounding bracelet |
US7724491B2 (en) | 2006-09-14 | 2010-05-25 | Earth Fx, Inc. | Method of treating inflammation and autoimmune diseases |
US8257385B2 (en) * | 2007-12-31 | 2012-09-04 | Daniel Karnwie-Tuah | Facelift device |
US20140356295A1 (en) * | 2013-06-03 | 2014-12-04 | R.J. Reynolds Tobacco Company | Cosmetic compositions comprising tobacco seed-derived component |
CN204121448U (en) * | 2014-10-29 | 2015-01-28 | 周静 | Lift facial film |
US9101195B2 (en) * | 2013-04-23 | 2015-08-11 | Victor Owoc | Article and method for preventing sleep lines |
US9161958B2 (en) | 2010-08-19 | 2015-10-20 | Johnson & Johnson Consumer Inc. | Methods of treating cellulite |
US20170027878A1 (en) | 2015-07-28 | 2017-02-02 | Elc Management Llc | Sheet Packs For Treating Facial Or Body Surfaces |
US20170216584A1 (en) * | 2016-01-29 | 2017-08-03 | Insung Information Co., Ltd. | Sheet mask for iontophoresis and mask assembly using the same |
-
2018
- 2018-01-05 US US15/863,174 patent/US11109661B2/en active Active
Patent Citations (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB191107396A (en) * | 1910-03-28 | 1911-10-05 | Eugene Joseph Mccarthy | Massaging Apparatus. |
US1678970A (en) * | 1926-11-05 | 1928-07-31 | Arlen Olga Louise | Facial bandage |
US2728339A (en) * | 1954-09-10 | 1955-12-27 | Elmhirst Kathleen | Facial mask |
US4150418A (en) | 1977-08-12 | 1979-04-17 | Charleswater Products, Inc. | Electrically conductive footwear |
US4201433A (en) * | 1978-07-06 | 1980-05-06 | Fargo Manufacturing Company, Inc. | Grounding connector |
US4249226A (en) | 1979-02-22 | 1981-02-03 | Minnesota Mining And Manufacturing Company | Grounding strap |
US4642912A (en) | 1984-05-02 | 1987-02-17 | Scholl, Inc. | Shoe insole |
US4926570B1 (en) | 1987-07-22 | 1996-03-19 | Lohmann Gmbh & Co Kg | Shoe inner sole particularly insole or welt |
US4926570A (en) | 1987-07-22 | 1990-05-22 | Lohmann Gmbh & Co. Kg | Shoe inner sole, particularly insole or welt |
US5091996A (en) * | 1989-03-13 | 1992-03-03 | Kirby Richard C | Face mask |
US5004425A (en) | 1989-10-10 | 1991-04-02 | Jes, L.P. | Magnetic snap assembly for connecting grounding cord to electrically conductive body band |
US5233769A (en) | 1990-07-17 | 1993-08-10 | Spenco Medical Corporation | Electrically conductive shoe insole |
US5599546A (en) | 1992-06-16 | 1997-02-04 | Klein; Marvin E. | Medicinal facial mask |
US5576924A (en) | 1995-07-31 | 1996-11-19 | Hee; Roland | Heel grounding device |
US5935596A (en) | 1997-03-20 | 1999-08-10 | Chesebrough-Pond's Usa Co. | Delivery of skin benefit agents via adhesive strips |
US6003247A (en) | 1997-05-23 | 1999-12-21 | Steffe; Daniel D. | Anti-static boot having a conductive upper |
US6237256B1 (en) | 1998-08-12 | 2001-05-29 | Sunnybrook And Women's College Health Sciences Centre | Balance-enhanced insert for footwear |
US6682779B1 (en) | 1999-09-24 | 2004-01-27 | Henkel Kommanditgesellschaft Auf Aktien | Coating means for elastomers |
KR20010094548A (en) * | 2000-03-31 | 2001-11-01 | 유상옥,송운한 | Skin Care Cosmetic Composition |
US7055266B2 (en) | 2002-04-01 | 2006-06-06 | Wayne Elsey | Electrostatically dissipative athletic shoe |
US6707659B2 (en) | 2002-06-18 | 2004-03-16 | Roland Hee | Heel grounder |
US20040161435A1 (en) | 2003-02-14 | 2004-08-19 | Gupta Shyam K. | Skin Firming Anti-Aging Cosmetic Mask Compositions |
US20040173220A1 (en) | 2003-03-06 | 2004-09-09 | Harry Jason D. | Method and apparatus for improving human balance and gait and preventing foot injury |
US20040219124A1 (en) | 2003-05-01 | 2004-11-04 | Gupta Shyam K. | Cosmetic and Pharmaceutical Masks Based on Ion-Pair Delivery System |
US7212392B2 (en) | 2005-06-15 | 2007-05-01 | Earth Fx | Personal body grounding system instrumentation and process |
US20090130040A1 (en) | 2006-04-14 | 2009-05-21 | Lvmh Recherche | Cosmetic rinsable mask type composition for skin care |
US7724491B2 (en) | 2006-09-14 | 2010-05-25 | Earth Fx, Inc. | Method of treating inflammation and autoimmune diseases |
US7609503B2 (en) | 2007-11-12 | 2009-10-27 | Roland Hee | Insulated metal grounding bracelet |
US8257385B2 (en) * | 2007-12-31 | 2012-09-04 | Daniel Karnwie-Tuah | Facelift device |
US9161958B2 (en) | 2010-08-19 | 2015-10-20 | Johnson & Johnson Consumer Inc. | Methods of treating cellulite |
US9101195B2 (en) * | 2013-04-23 | 2015-08-11 | Victor Owoc | Article and method for preventing sleep lines |
US20140356295A1 (en) * | 2013-06-03 | 2014-12-04 | R.J. Reynolds Tobacco Company | Cosmetic compositions comprising tobacco seed-derived component |
CN204121448U (en) * | 2014-10-29 | 2015-01-28 | 周静 | Lift facial film |
US20170027878A1 (en) | 2015-07-28 | 2017-02-02 | Elc Management Llc | Sheet Packs For Treating Facial Or Body Surfaces |
US20170216584A1 (en) * | 2016-01-29 | 2017-08-03 | Insung Information Co., Ltd. | Sheet mask for iontophoresis and mask assembly using the same |
Also Published As
Publication number | Publication date |
---|---|
US20180125205A1 (en) | 2018-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2591667C (en) | Apparatus for the electro-inhibition of facial muscles | |
US7373204B2 (en) | Implantable device and method for treatment of hypertension | |
US8825174B2 (en) | Therapeutic electric antioxidant clothing apparatus and method | |
KR102476626B1 (en) | System and method for preventing alopecia | |
CN102362846B (en) | Skin radiation-preventing composition | |
US11109661B2 (en) | System, device and method of facial remodeling | |
KR200487759Y1 (en) | Funtionality health sillicon patch | |
CN108888562A (en) | A kind of eye mask and preparation method thereof | |
KR200468146Y1 (en) | Mask | |
JP6525245B2 (en) | Electrotherapy device | |
KR101427604B1 (en) | electrical stimulation devices for rectify a cervical spine, treatment of pain of electrical stimulation and LED | |
CN216456540U (en) | Transcranial electrical stimulation cap acting on forehead leaf | |
CN208852045U (en) | It is a kind of for treating the nail covers of onychomycosis | |
KR101375312B1 (en) | Mask using micro electrical current | |
KR102566702B1 (en) | Apparatus for beauty treatment using anion | |
KR101299151B1 (en) | Mask generating micro electrical current by power supply | |
US8457765B2 (en) | Ear clip with pole | |
KR20120014225A (en) | Mask using microcurrent | |
KR101526939B1 (en) | Mask using micro electrical current | |
KR20120000845U (en) | Mask using micro electrical current | |
KR200463511Y1 (en) | Mask using micro electrical current | |
US20240164977A1 (en) | Grounding Skin Scraper | |
CN110545881A (en) | A pain relief pad for multifunctional magnetic therapy | |
KR101116131B1 (en) | Mask using micro electrical current | |
CN107728457A (en) | A kind of wrist-watch with energetic particles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: NEW YOU LIFT, LLC, COLORADO Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:FULTON, RICHARD EUSTIS;TODOROV, GERMAN;REEL/FRAME:044545/0815 Effective date: 20180104 |
|
FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: AWAITING TC RESP., ISSUE FEE NOT PAID |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Year of fee payment: 4 |